Chronic kidney disease (CKD) and hypertension (HTN) share a complex, bidirectional relationship—declining kidney function raises blood pressure, while sustained hypertension accelerates CKD progression. This harmful feedback loop is well-documented in both animal models and clinical studies. In the Chronic Renal Insufficiency Cohort (CRIC) study of 3612 adults with CKD, 86% reported hypertension compared to 29% in the general population. Hypertension becomes increasingly prevalent and harder to control as CKD advances.^[1] Intensive blood pressure lowering has been shown to reduce the risk of kidney failure events by 17% and end-stage kidney disease by 18%, especially in patients with proteinuria.^[2] Effective management of hypertension in CKD includes identifying the underlying renal pathology, setting appropriate BP goals, and implementing both non-pharmacological and pharmacological interventions.